How a Community Infusion Network Cut Denial Risk by 68% and Saved $1.4M in One Year

Most billing teams manage to deny one claim at a time, after the remittance already shows a problem. Infusion denial risk is a different way of looking at the same data. Instead of reacting to individual denials, it treats denial likelihood as something that can be measured, scored, and reduced before a claim is ever submitted.

At Infusion Billing Services, we recently completed a full-year engagement with a community infusion network whose individual sites were each managing denials reactively, with no shared view of where risk was actually concentrated. This case study explains what infusion denial risk means as a working concept, where this network’s risk was clustered, and how reducing it across every site saved $1.4 million in one year.

What Is Infusion Denial Risk

Infusion denial risk is how likely a claim is to be denied, based on warning signs you can spot before the claim ever goes out. Instead of waiting for a denial and then figuring out what went wrong, this approach looks at the same handful of factors every time: eligibility and authorization status, whether the diagnosis matches current coverage policy, how well the drug charge was documented, and whether a contracted usage cap was hit. Since all of these can be checked ahead of time, the risk can be scored and fixed before the infusion happens, not after.

This changes how a practice spends its prevention effort. A reactive team treats every denial as a brand new problem. A team working from infusion denial risk instead asks which warning signs are present on a claim and fixes those before submitting it. Two claims can carry the exact same denial code and still come from very different root causes, and this approach is built to catch that difference early.

It also matters more as a network grows. One site might notice its own denial pattern without ever learning that three other sites are fighting the same underlying issue. Tracking infusion denial risk centrally is what makes that shared pattern visible.

Client Snapshot

Our client was a community infusion network operating eight sites across a single region, administering biologic, immunoglobulin, and specialty oncology infusions to a combined patient base of roughly 3,000 patients annually. Each site had historically managed its own billing and denial process independently, with no shared reporting or risk framework across the network. We measured infusion denial risk across all eight sites over a twelve-month engagement, starting with a baseline assessment of where risk was concentrated before any changes were made. The review found that denial risk clustered heavily around five identifiable factors, present in varying degrees at every site in the network but never tracked centrally or addressed as a shared problem.

Risk Factor 1: No Shared Eligibility and Authorization Standard Across Sites

Each site had built its own eligibility process independently over the years, and no two looked alike. One site verified referral status and prior authorization as a matter of routine. Another only checked general coverage, because the staff member who originally set up that process had since left and nothing was ever formalized. This was not a single gap repeated eight times. It was eight different processes of varying quality, and infusion denial risk was highest wherever a site’s informal process happened to be weakest.

Problem:

• Every site had its own ad hoc eligibility process, with no shared definition of what “complete” meant
• Smaller sites had no dedicated verification staff and relied on whoever was available that day
• Network leadership had no visibility into which sites were carrying the most risk, or why

Fix:

• Replaced eight informal processes with one standardized eligibility and authorization checklist
• Required a recheck before each visit in a recurring infusion series, not just the first
• Gave network leadership a shared dashboard showing verification completeness by site

Risk Factor 2: Site-Specific Payer Relationships Creating Coverage Blind Spots

Because the network spanned multiple communities, different sites had grown their own relationships with different subsets of local and regional payers, and in some cases fell under different MAC jurisdictions with their own LCD policy. A diagnosis that supported coverage at one site could fail LCD requirements at another, for the exact same drug, simply because the two sites answered to different coverage policies. No one had ever mapped this out, so a diagnosis coding habit that worked fine at the flagship site quietly generated infusion denial risk when applied at a newer or more distant location.

Problem:

• Sites in different MAC jurisdictions were subject to different LCD requirements for the same drug
• Diagnosis and coding habits were shared informally across sites without accounting for that difference
• No one had mapped which sites fell under which coverage policy for the network’s highest volume drugs

Fix:

• Built a site-by-site map of applicable LCD and payer coverage policy for every high volume drug
• Distributed coverage policy updates to the specific sites they applied to, not the network as a whole
• Required diagnosis verification against the correct site-specific policy before claim submission

Risk Factor 3: Charge Capture Quality Depended on Which Site Treated the Patient

The network’s larger sites had EHR-integrated charge capture that recorded dose, discarded amount, and NDC data automatically. Smaller and more rural sites, without the same technology investment, still relied on paper notes that a biller reconstructed by hand after the visit. A patient’s infusion denial risk on this front had less to do with their diagnosis or drug and more to do with which site’s parking lot they happened to pull into, which is exactly the kind of infusion denial risk a single-site case study would never surface.

Problem:

• Charge capture technology and process varied by site’s size and resources, not by any clinical factor
• Smaller sites had no structured field for discarded drug amounts and relied on free text notes
• Manual reconstruction at under-resourced sites introduced errors the better-equipped sites never saw

Fix:

• Extended structured, EHR-integrated charge capture fields to every site regardless of size
• Required dose, discard, and NDC data to be captured at the point of administration network wide
• Gave smaller sites the same documentation tools the flagship site already had

Risk Factor 4: Contract Terms Tracked Locally, Never Shared Across the Network

Several payer contracts capped administration hours or drug units within a defined period, but knowledge of those caps lived with whichever site manager had originally signed the agreement. When staff moved between sites, or a patient transferred locations mid-series, that institutional knowledge did not travel with them. The same contracted cap could be well understood at one site and a complete unknown, and a real source of infusion denial risk, at another.

Problem:

• Contract knowledge lived with individual site managers instead of a shared network resource
• Patients transferring between sites carried no record of caps already accumulated elsewhere
• A cap well known at the site that negotiated it was invisible to every other site under the same contract

Fix:

• Centralized every payer contract and its caps into one network-wide reference, not site-held knowledge
• Built a shared record following the patient across sites so accumulated units transferred with them
• Assigned network-level, not site-level, ownership of contract cap tracking

Risk Factor 5: No Shared Denial Data or Risk Intelligence Across Sites

Even where an individual site resolved a denial well, that resolution stayed local. Nothing connected one site’s hard-won fix to the identical problem quietly building at another site three towns over. Every location was solving the same infusion denial risk factors independently and often years apart from each other.

Problem:

• Denial resolution data stayed siloed at the site that resolved it
• No shared scoring model existed to flag claims carrying elevated risk in advance, network wide
• A fix discovered at one site had no mechanism to reach the other seven

Fix:

• Built a shared infusion denial risk score applied to claims before submission across every site
• Fed resolved denial data from every site into one shared scoring model, not eight separate ones
• Reviewed network-wide risk trends monthly so a fix at one site became a fix at all eight

How the Savings Broke Down

Each risk factor addressed contributed a distinct, separately tracked portion of the total savings.

These five figures were tracked independently by risk factor throughout the engagement and sum directly to the full $1.4 million. Eligibility and authorization risk reduction represented the largest share because it was the most common risk factor present across every site in the network, and it addressed claims before any other risk factor had a chance to compound on top of it.

Financial Recovery Results

Beyond the savings breakdown, several network-wide metrics shifted substantially across the twelve-month engagement.

Key Takeaways

• Infusion denial risk treats denial likelihood as a measurable, preventable factor rather than something only visible after a claim is denied
• Eligibility and authorization gaps are typically the largest single driver of infusion denial risk across a multi-site network
• Diagnosis coverage alignment, charge capture accuracy, and contracted utilization caps each contribute distinct, trackable risk
• A shared scoring model turns infusion denial risk into a network-wide asset rather than something each site rediscovers independently
• Reducing infusion denial risk before submission produces larger, more sustainable savings than managing denials reactively after the fact

Conclusion

Reducing infusion denial risk at network scale depends on measuring it centrally and addressing the underlying factors before claims go out, not managing denials site by site after they occur. As this case shows, addressing eligibility and authorization gaps, coverage policy misalignment, charge capture inconsistency, utilization cap tracking, and predictive scoring together cut infusion denial risk by 68 percent and saved $1.4 million in one year.

If your infusion network is managing denials independently across sites with no shared view of where risk is concentrated, we can help. Infusion Billing Services can measure your infusion denial risk across every location and build a standardized, network-wide plan to reduce it.

Contact Infusion Billing Services today for a complete infusion denial risk assessment across your network